Abstract
Introduction: TheC9orf72repeat expansion has been reported as a negative prognostic factor in amyotrophic lateral sclerosis (ALS). We have examined the prognostic impact of theC9orf72repeat expansion in European subgroups based on gender and site of onset.Methods: C9orf72status and demographic/clinical data from 4925 patients with ALS drawn from 3 prospective ALS registers (Ireland, Italy and the Netherlands), and clinical data sets in the UK and Belgium. Flexible parametric survival models were built including known prognostic factors (age, diagnostic delay and site of onset), gender and the presence of an expanded repeat inC9orf72.These were used to explore the effects ofC9orf72on survival by gender and site of onset. Individual patient data (IPD) meta-analysis was used to estimate HRs for results of particular importance.Results: 457 (8.95%) of 4925 ALS cases carried theC9orf72repeat expansion. A meta-analysis ofC9orf72estimated a survival HR of 1.36 (1.18 to 1.57) for those carrying the expansion. Models evaluating interaction between gender andC9orf72repeat expansions demonstrated that the reduced survival due toC9orf72expansion was being driven by spinal onset males (HR 1.56 (95% CI 1.25 to 1.96).Conclusions: This study represents the largest combined analysis of the prognostic characteristics of theC9orf72expansion. We have shown for the first time that the negative prognostic implication of this variant is driven by males with spinal onset disease, indicating a hitherto unrecognised gender-mediated effect of the variant that requires further exploration.

This publication has 31 references indexed in Scilit: